Researchers in Sweden have identified a new way to predict risk of type 2 diabetes many years before a typical diabetes diagnosis is made.
Anders Rosengren, of the Lund University Diabetes Centre (LUDC), and colleagues, say they have shown that people with "above-average levels of a protein called SFRP4 in the blood are five times more likely to develop diabetes in the next few years than those with below-average levels".
The finding comes from studies that compared insulin-producing beta cells from people with diabetes with those from non-diabetic individuals. The LUDC researchers found that cells from diabetics have significantly higher levels of the SFRP4 protein, which plays a role in inflammatory processes in the body.
The team then measured levels of SFRP4 in the blood of non-diabetics three times every three years and discovered that over a third (37 per cent) of those with higher concentrations developed type 2 diabetes during the study, compared with just nine per cent of those with lower-than-average levels.
According to Rosengren, this makes the protein a "strong risk marker" that is present in the bloodstream several years before diagnosis. In addition, the marker works independently of other known risk factors for type 2 diabetes such as obesity.
"If we can point to an increased risk of diabetes in a middle-aged individual of normal weight using a simple blood test, up to ten years before the disease develops, this could provide strong motivation to them to improve their lifestyle to reduce the risk," Rosengren said.
"In the long term, our findings could also lead to new methods of treating type 2 diabetes by developing ways of blocking the protein SFRP4 in the insulin-producing beta cells and reducing inflammation, thereby protecting the cells."
The findings, published in recent issue of Cell Metabolism, mark the first time scientists have established a link between SFRP4 and diabetes risk, as well as the first link between the metabolic disease and inflammation in beta cells - inflammation is believed to weaken these pancreatic cells and prevent them from producing sufficient insulin.
Blood marker could lead to earlier diagnosis of type 2 diabetes
Fri, 09 Nov 2012
Your comments may be moderated. Please report any spam, illegal, offensive or libellous posts.
Also related to this storyBMI calculator
Diabetes guides and information
Diabetes tools and calculators
Products for diabetics
Specialist diabetic finance and insurance
Diabetes diet guides and recipes
Diabetes healthcare professionals
Real life diabetic stories
Join the diabetes forum
Read the latest diabetes news
Newly diagnosed with diabetes
Personal fitness pilot to benefit type 2 diabetics in Scottish Borders
Pumping iron can protect against type 2 diabetes and heart disease
Legumes can improve glycemic control and lower CVD risk in type 2 diabetics
Type 2 diabetes risk much higher for psoriasis sufferers
Huge growth in sales forecast for type 2 diabetes drugs
Sitting all day doubles the risk of type 2 diabetes
Type 2 diabetics who exercise can prevent early cardiovascular aging
80 per cent of type 2 diabetics suffer hypoglycemia
Vitamin K1 cuts risk of type 2 diabetes
High risk of type 2 diabetes in east London
Type 2 diabetes screening unlikely to cut death rates
Politicians assessed for type 2 diabetes risk
Drug offers new approach for type 2 diabetes treatment
Lack of sleep ups future type 2 diabetes risk for teens
Different balance of intestinal bacteria linked with type 2 diabetes
Blocking fat storage protein may reverse type 2 diabetes
Type of body fat determines type 2 diabetes risk
20 minutes of daily exercise can slash kids type 2 diabetes risk
Type 2 diabetes ups breast cancer risk in older women
Zealand Pharma begins clinical development of type 2 diabetes drug
Type 2 diabetics at greater risk of UTIs
Reducing red meat intake could slash type 2 diabetes rates